Jade Biosciences (JBIO) Shares Outstanding (Weighted Average) (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $57.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1731.0% year-over-year to $57.8 million; the trailing twelve-month figure through Mar 2026 stood at $57.8 million (up 1731.0% YoY), and the FY2025 full-year result was $31.4 million, up 893.82% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $57.8 million, up from $31.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $57.8 million in Q1 2026 and bottomed at $3.2 million in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $24.8 million (2023), against an average of $23.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) surged 9942.31%; it then sank 88.65% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $24.5 million in 2022, then gained by 7.6% to $26.3 million in 2023, then sank by 88.02% to $3.2 million in 2024, then jumped by 893.82% to $31.4 million in 2025, then jumped by 84.24% to $57.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $57.8 million (Q1 2026), $31.4 million (Q4 2025), and $39.6 million (Q3 2025), per Business Quant data.

Peer Comparison